Stocks
Deciphera Pharmaceuticals (DCPH) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -11.5 | -10.1 | -1.05 | -5.52 | -5.23 | -3.99 | ||
| Changes by years, y/y, % | +148% | -12% | -90% | +424% | -5% | +2.5% | |||
Deciphera Pharmaceuticals. EV/EBITDA
Deciphera Pharmaceuticals. EV/EBITDA, changes, %
Deciphera Pharmaceuticals (DCPH) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.10 | -4.75 | -3.87 | -5.55 | -5.77 | -3.99 | |
| Changes by years, y/y, % | +356% | +105% | -25% | -1% | +13% | |||
| Changes by quarters, q/q, % | -9% | -7% | -19% | +44% | +4% | |||
